In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS) - Concepedia

Concepedia

Publication | Open Access

In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)

DOI Full Paper Access

79

Citations

26

References

2018

Year

Carlotta Ranieri, Silvia Di Tommaso, Daria Carmela Loconte, Valentina Grossi, Paola Sanese, Rosanna Bagnulo, Francesco Susca, Giovanna Forte, Alessia Peserico, Annunziata De Luisi,

References

	Year	Citations

Page 1